The anticancer effect was supposed to be the result of apoptosis induced by Peficitinib, according to immunostaining of the excised tumor, which was positive for cleaved caspase-3 and negative for RIPK3 (Supplementary Fig. 4d). The gene discussed is RIPK3; the disease is neoplasm.